Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

BNO
United States Brent Oil Fund, LP
stock NYSE ETF

At Close
Jul 31, 2026 3:59:54 PM EDT
50.37USD+1.420%(+0.71)1,482,806
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 31, 2026 9:28:30 AM EDT
50.52USD+1.732%(+0.86)31,493
After-hours
Jul 31, 2026 4:59:30 PM EDT
51.50USD+2.254%(+1.13)25,925
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 14, 2022
07:09AM EST  Bionomics To Ring Nasdaq Stock Market Closing Bell On Jan. 14   RTTNews
07:07AM EST  Bionomics Limited (Nasdaq: BNOX, ASX: BNO) to Ring the Nasdaq Stock Market   PR Newswire
Jan 12, 2022
06:00AM EST  Bionomics Limited participated in the H.C Wainwright BioConnect Conference   PR Newswire
Jan 3, 2022
06:00AM EST  Bionomics Initiates Phase 2 PREVAIL Study of BNC210 for the Acute Treatment of   PR Newswire
Dec 16, 2021
06:03AM EST  Bionomics Prices IPO Of 1.622 Mln ADSs At US$12.35/ADSs   RTTNews
06:01AM EST  Bionomics Limited Announces Pricing of Initial Public Offering in the United   PR Newswire
Dec 13, 2021
08:16AM EST  Bionomics Launches IPO Of 1.62 Mln ADSs   RTTNews
08:14AM EST  Bionomics Limited Announces Launch of Proposed Initial Public Offering in the   PR Newswire
Dec 1, 2021
06:31AM EST  Bionomics: FDA Grants Fast Track Designation To BNC210 For Acute Treatment Of Social Anxiety Disorder   RTTNews
06:01AM EST  U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute   PR Newswire
Nov 23, 2021
06:39AM EST  Bionomics Files Registration Statement For Proposed IPO In U.S.   RTTNews
06:37AM EST  Bionomics Files Registration Statement for Proposed Initial Public Offering in   PR Newswire
Nov 1, 2021
06:03AM EDT  Bionomics Receives FDA Clearance Of IND For Evaluation Of BNC210 In A Phase 2 Social Anxiety Disorder PREVAIL Study   RTTNews
06:01AM EDT  Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2   PR Newswire
Sep 20, 2021
06:02AM EDT  Bionomics Says Prepares BNC210 For Start Of Phase 2 Acute Treatment Of Social Anxiety Disorder Trial   RTTNews
06:00AM EDT  Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social   PR Newswire
Aug 2, 2021
06:06AM EDT  Bionomics Announces Plans To Conduct U.S. IPO Of ADSs And A Concurrent Listing Of ADSs On Nasdaq   RTTNews
06:00AM EDT  Bionomics Announces Plans to Conduct U.S. Initial Public Offering   PR Newswire
Jul 6, 2021
06:04AM EDT  Bionomics Initiates Phase 2b ATTUNE Study Of BNC210 In Post-Traumatic Stress Disorder   RTTNews
06:01AM EDT  Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD   PR Newswire
May 10, 2021
06:01AM EDT  Bionomics BNC210 Expansion into Social Anxiety Disorder   PR Newswire
Apr 9, 2021
06:00AM EDT  Bionomics Successfully Completes A$22.9 million Equity Raise   PR Newswire
Feb 22, 2021
06:05AM EST  Bionomics Announces Positive Pharmacokinetic Results From 7-day Dosing Study   RTTNews
06:01AM EST  Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure   PR Newswire
Feb 17, 2021
06:00AM EST  Joint feasibility assessment of Bionomics' BNC210 and EmpathBio's MDMA   PR Newswire
Feb 10, 2021
06:01AM EST  $16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial   PR Newswire
Dec 4, 2020
07:08AM EST  Crude Futures Rise On OPEC+ Output Compromise, Potential Brent Oil Benchmark Addition   Benzinga
Nov 12, 2020
03:58AM EST  Oil Prices Rise On Hopes Of OPEC+ Extending Supply Curbs   Benzinga
Sep 3, 2020
04:32AM EDT  New investors Thiel and Novogratz introduced to Bionomics by Apeiron Investment   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC